http://www.acc.org/Feed?clinicalTopicID=3bf13d0e-30db-413f-b1ef-03f397769a1a Clinical Topic Feed: Valvular Heart Disease en /Latest-in-Cardiology/Journal-Scans/2026/07/07/13/29/Novel-TEER-System For high-risk patients with primary mitral valve regurgitation (MR), the novel Neonova transcatheter edge-to-edge repair (TEER) system was safe and effective, with a high rate of event-free survival and sustained clinical and echocardiographic improvements through two years, according to a prospective study published June 29 in JACC: Asia. 1783537920000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/01/12/47/eagles-eye-view-01jul2026 In this week’s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM). 1782910140000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1782907740000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1782902880000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/PARTNER-3 TAVR and surgery demonstrated comparable and sustained valve durability in low-risk patients with symptomatic severe aortic stenosis (AS), with both approaches showing low and similar rates of structural valve deterioration (SVD), all-cause bioprosthetic valve failure (BVF) and reintervention through seven years... 1782845400000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/23/13/25/PARTNER-2A-P2S3i-Registry The rates of mortality and reintervention at 10 years were higher in patients at intermediate risk who underwent TAVR with the second-generation SAPIEN XT valve than those who underwent surgery in the PARTNER 2A trial, according to an analysis published June 16 in a valvular heart disease focus issue of JACC. 1782399420000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/17/17/38/CMS-Proposes-Updates-to-TAVR-National-Coverage-Determination The Centers for Medicare and Medicaid Services (CMS) released a proposed decision memo on the National Coverage Determination (NCD) for TAVR, introducing changes to coverage pathways, evidence development and quality oversight. 1781718060000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/16/16/01/eagles-eye-view-17jun2026 In this week’s View, Dr. Eagle highlights a study showing race and sex disparities in M-TEER outcomes, with Black patients presenting with more advanced disease, lower success, and higher heart failure readmissions than White patients, and women having lower success rates than men. 1781701440000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/08/17/44/Racial-and-Sex-Disparities-in-M-TEER-Outcomes Black patients undergoing mitral transcatheter edge-to-edge repair (M-TEER) were more likely to present with more advanced disease, had lower procedural success and higher heart failure (HF) readmission rates vs. White patients, and female patients had lower procedural success rates vs. male patients... 1780940640000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/13/18/Managing-CVD-in-Older-Adults-With-Cognitive-Impairment Older adults with cardiovascular (CV) risk factors or established cardiovascular disease (CVD) are at increased risk of cognitive impairment (CI). This risk is observed across several conditions, including hypertension, atrial fibrillation (AF), heart failure, and coronary artery disease. 1780331400000 Articles and Stories